- Home
- MAMK vs TPST Comparison
MAMK vs TPST Comparison
Compare MAMK & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAMK
- TPST
- Stock Information
- Founded
- MAMK 2007
- TPST 2011
- Country
- MAMK China
- TPST United States
- Employees
- MAMK N/A
- TPST N/A
- Industry
- MAMK Apparel
- TPST Biotechnology: Pharmaceutical Preparations
- Sector
- MAMK Consumer Discretionary
- TPST Health Care
- Exchange
- MAMK Nasdaq
- TPST Nasdaq
- Market Cap
- MAMK 43.2M
- TPST 45.5M
- IPO Year
- MAMK 2025
- TPST N/A
- Fundamental
- Price
- MAMK N/A
- TPST N/A
- Analyst Decision
- MAMK
- TPST Hold
- Analyst Count
- MAMK 0
- TPST 3
- Target Price
- MAMK N/A
- TPST $30.00
- AVG Volume (30 Days)
- MAMK 103.4K
- TPST 43.4K
- Earning Date
- MAMK 01-01-0001
- TPST 11-11-2025
- Dividend Yield
- MAMK N/A
- TPST N/A
- EPS Growth
- MAMK N/A
- TPST N/A
- EPS
- MAMK 0.12
- TPST N/A
- Revenue
- MAMK $21,434,100.00
- TPST N/A
- Revenue This Year
- MAMK N/A
- TPST N/A
- Revenue Next Year
- MAMK N/A
- TPST N/A
- P/E Ratio
- MAMK $23.16
- TPST N/A
- Revenue Growth
- MAMK N/A
- TPST N/A
- 52 Week Low
- MAMK $1.87
- TPST $5.35
- 52 Week High
- MAMK $4.00
- TPST $20.67
- Technical
- Relative Strength Index (RSI)
- MAMK N/A
- TPST 58.22
- Support Level
- MAMK N/A
- TPST $8.87
- Resistance Level
- MAMK N/A
- TPST $11.07
- Average True Range (ATR)
- MAMK 0.00
- TPST 0.47
- MACD
- MAMK 0.00
- TPST 0.07
- Stochastic Oscillator
- MAMK 0.00
- TPST 87.66
About MAMK MaxsMaking Inc. Class A Ordinary Shares
MaxsMaking Inc is a manufacturer of consumer goods with a focus on technology and innovation. It is serving small and medium-sized enterprises and individual e-commerce sellers with their needs for small batch products, It currently use cotton cloth, nylon cloth, polyester, recycled polyethylene terephthalate (rPET) and other materials to produce backpacks, shopping bags, aprons, tablecloths and other consumer goods. It serve enterprises, schools, government agencies, non-profit organizations, e-commerce sellers and various groups and organizations to meet their needs for small-batch products.
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.